Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

A review of sleep disturbance in hepatitis C.

Sockalingam S, Abbey SE, Alosaimi F, Novak M.

J Clin Gastroenterol. 2010 Jan;44(1):38-45. doi: 10.1097/MCG.0b013e3181b314ea. Review.

PMID:
19730115
2.

Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.

Quelhas R, Lopes A.

J Psychiatr Pract. 2009 Jul;15(4):262-81. doi: 10.1097/01.pra.0000358313.06858.ea. Review.

PMID:
19625882
3.

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.

Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K.

Hepatology. 2003 Feb;37(2):443-51.

PMID:
12540795
4.

Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update.

Sockalingam S, Links PS, Abbey SE.

J Viral Hepat. 2011 Mar;18(3):153-60. doi: 10.1111/j.1365-2893.2010.01393.x. Epub 2010 Nov 10. Review.

PMID:
21070503
5.

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

Jacobson KR, Murray K, Zellos A, Schwarz KB.

J Pediatr Gastroenterol Nutr. 2002 Jan;34(1):52-8.

PMID:
11753165
6.

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.

Maddock C, Baita A, Orrù MG, Sitzia R, Costa A, Muntoni E, Farci MG, Carpiniello B, Pariante CM.

J Psychopharmacol. 2004 Mar;18(1):41-6.

PMID:
15107183
7.

[Treatment of chronic hepatitis C in special groups].

Bourlière M, Halfon P, Portal I.

Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B238-47. Review. French. No abstract available.

PMID:
12180296
8.

Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?

Schaefer M, Heinz A, Backmund M.

Addiction. 2004 Sep;99(9):1167-75. Review.

PMID:
15317637
9.

The effect of early treatment in children with chronic hepatitis.

Hartman C, Berkowitz D, Rimon N, Shamir R.

J Pediatr Gastroenterol Nutr. 2003 Sep;37(3):252-7.

PMID:
12960645
10.

Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.

Hauser P.

Gastroenterol Clin North Am. 2004 Mar;33(1 Suppl):S35-50.

PMID:
15081102
11.

Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.

Kraus MR, Schäfer A, Faller H, Csef H, Scheurlen M.

Aliment Pharmacol Ther. 2002 Jun;16(6):1091-9.

12.

Effect of ribavirin, in combination with interferon in patients with hepatitis C, on the bleeding risk associated with selective serotonin reuptake inhibitors.

Honda T, Katano Y, Toyoda H, Hayashi K, Ishigami M, Nakano I, Goto H, Yamamoto K, Takamatsu J.

J Clin Psychiatry. 2008 Apr;69(4):679-80. No abstract available.

PMID:
18507491
13.

A case of interferon alpha-induced manic psychosis in chronic hepatitis C.

Kanno A, Yamada M, Abe M, Okamoto Y.

Tohoku J Exp Med. 1999 Jan;187(1):79-82.

14.

Treatment of chronic hepatitis C in special groups.

Pol S, Zylberberg H, Fontaine H, Bréchot C.

J Hepatol. 1999;31 Suppl 1:205-9. Review.

PMID:
10622589
15.

Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.

Schäfer M, Boetsch T, Laakmann G.

Addiction. 2000 Jul;95(7):1101-4.

PMID:
10962774
16.

Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review.

Schäfer A, Wittchen HU, Seufert J, Kraus MR.

Int J Methods Psychiatr Res. 2007;16(4):186-201. doi: 10.1002/mpr.229. Review.

PMID:
18188838
17.

Ribavirin may be an important factor in IFN-induced neuropsychiatric effects.

Asnis GM, De La Garza R 2nd, Miller AH, Raison CL.

J Clin Psychiatry. 2004 Apr;65(4):581; author reply 581-2. No abstract available.

PMID:
15119925
18.

Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.

Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, Stanzione M, Ascione T, De Sena R, Campanone A, Filice G, Piccinino F.

Aliment Pharmacol Ther. 2002 Sep;16(9):1633-9.

19.

Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C.

Hilsabeck RC, Hassanein TI, Ziegler EA, Carlson MD, Perry W.

J Int Neuropsychol Soc. 2005 Jan;11(1):16-22.

PMID:
15686604
20.

Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.

Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.

Med Sci Monit. 2000 Sep-Oct;6(5):964-70.

PMID:
11208439

Supplemental Content

Support Center